로딩 중…
지수 로딩 중…
KOREAN DRUG CO., LTD.
014570· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩3,350-1.18%
2026-06-19
Price Chart
KOREAN DRUG CO., LTD.-31.91%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 36.85B KRW |
| Revenue | 62.76B KRW |
| Net Income | 2.21B KRW |
| Total Assets | 96.39B KRW |
| Net Assets | 82.31B KRW |
| Employees | 172 |
| Value | |
| P/E | 16.66x |
| P/B | 0.45x |
| PEG | 0.33x |
| P/S | 0.59x |
| EV/EBITDA | 12.14x |
| FCF Yield | 34.34% |
| Profitability | |
| ROE | 2.69% |
| ROA | 2.29% |
| Op. Margin | 3.60% |
| Revenue Growth | 1.92% |
| Earnings Growth | 49.88% |
| Financial Health | |
| Debt Ratio | 17.12% |
| Total Debt | 0 KRW |
| FCF | 12.65B KRW |
| Cash | 9.40B KRW |
| Current Ratio | 6.63x |
| Net Debt/EBITDA | -4.16x |
| Dividend | |
| Div. Yield | 5.31% |
| Div. Growth | 12.50% |
| Performance | |
| 1Y Return | -31.91% |
| 1M Return | -10.19% |
| From 52W High | -35.20% |
| 1Y MDD | -37.29% |
| Trading | |
| Volume | 7,362 shares |
| Foreign Own. | 3.04% |
| Per Share | |
| EPS | 628 KRW |
| BPS | 7,604 KRW |
Company Info
Koryo Pharm, established in 1980, manufactures and sells pharmaceuticals, listing on the KOSDAQ market in 2000. The company produces and distributes over-the-counter drugs, including Haben, a leading cold medicine in Korea, along with professional pharmaceuticals for central nervous system diseases such as dementia and epilepsy. Committed to public health, it conducts research and development for new drugs and generics, with its R&D capabilities recognized through patent applications and technology certifications. Koryo Pharm is headquartered in Icheon, Gyeonggi-do.